Nova Advanced Tissue Engineering Limited
11083393
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 27/11/2017
DEPUTY MANAGING DIRECTOR
BRITISH · ENGLAND · Age 40
Also on 8 other boards
director · Since 27/11/2017
DIRECTOR
BRITISH · UNITED KINGDOM · Age 78
Also on 10 other boards
secretary · Since 01/01/2024
Persons with Significant Control
Nova Bio-Pharma Holdings Limited
Martin House, Gloucester Crescent, Wigston, LE18 4YF
Reg: 06600173 · Companies House · Limited Company
Notified 27/11/2017
CompanyRankvs 79539+ SIC 99999 peers26
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2026
Net Worth
£1
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£1
Working capital
Current Assets
£1
Current Liabilities
—